216 results
Page 4 of 11
8-K
EX-99.1
h3vt5doilrxn1bm
28 Feb 22
FibroGen Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm
CORRESP
ztbiaygc2vz50z
20 Jan 22
Correspondence with SEC
12:00am
8-K
EX-99.1
riqbmgte3f9p xbcke
9 Nov 21
FibroGen Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
we16xmz
20 Aug 21
Other Events
12:00am
8-K
EX-99.1
063o1 l2gelhojurhz
11 Aug 21
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
8:30am
S-8
y4jw2o gjnd99f
9 Aug 21
Registration of securities for employees
5:28pm
S-8
EX-23.1
9b6vd
9 Aug 21
Registration of securities for employees
5:28pm
8-K
EX-99.1
fib1s51
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
2w56ei
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
8-K
d8xcnw3
27 May 21
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
EX-99.1
zr2vqullyabzy6w
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
mobmnlowvz4 o552
7 Apr 21
Regulation FD Disclosure
8:30am